Year: 2008
Type: article
Study design: Observational Study
Abstract: BACKGROUND: In patients infected with human immunodeficiency virus type 1 (HIV-1), HIV-1 DNA persists during highly active antiretroviral treatment, reflecting long-lived cellular reservoirs of HIV-1. Recent studies report an association between HIV-1 DNA levels, disease progression, and treatment outcome. However, HIV-1 DNA exists as distinct molecular forms that are not distinguished by conventional assays. METHODS: We analyzed HIV-1 RNA levels in plasma, CD4 cell counts, and levels of integrated and nonintegrated HIV-1 DNA in peripheral blood mononuclear cells (PBMCs) from patients with early or chronic infection before and during antiretroviral treatment. We also studied HIV-1 DNA decay in primary CD4 T cells infected in vitro. HIV-1 DNA was analyzed using an assay that is unaffected by the location of HIV-1 integration sites. RESULTS: HIV-1 RNA levels and total HIV-1 DNA levels decayed rapidly in patients during receipt of suppressive antiretroviral therapy. Ratios of total HIV-1 DNA levels to integrated HIV-1 DNA levels were high before initiation of therapy but diminished during therapy. Levels of linear nonintegrated HIV-1 DNA decayed rapidly in vitro (t (1/2) = 1- 4.8 days). CONCLUSION: Total HIV-1 DNA decays rapidly with suppression of virus replication in vivo. Clearance of HIV-1 DNA during the first 6 months of therapy reflects a disproportionate loss of nonintegrated HIV-1 DNA genomes, suggesting that levels of total HIV-1 DNA in PBMCs after prolonged virus suppression largely represent integrated HIV-1 genomes.
DOI: 10.1086/525283
Authors: Kersten K. Koelsch, Lin Liu, Richard Haubrich, Susanne May, Diane Havlir, Huldrych F. Günthard, Caroline C. Ignacio, Paula Campos‐Soto, Susan J. Little, Robert Shafer, Gregory K. Robbins, Richard T. D’Aquila, Yuji Kawano, Karen Young, Phillip Dao, Celsa A. Spina, Douglas D. Richman, Joseph K. Wong
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Awards: IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY, HIV Resistance and Treatment Strategies, G2291331489, Global Gene Regulation in CD4 T Cell Signaling, G2720898588, G2916982757, ADULT ACTG CENTRAL GROUP, G5697590470, Bridging the Gap HIV Trials and Clinical Practice, SAN DIEGO AIDS CLINICAL TRIAL UNIT, Southern California Primary Infection Program, HIV-1 Adaptation in the Central Nervous System, Training in HIV Translational Research, UCSF-Bay Area Center for AIDS Research
OpenAlex ID: W2124721471
